Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
European Journal of Medical Genetics|April 6, 2017
Caution in interpretation of disease causality for heterozygous loss-of-function variants in the MYH8 gene associated with autosomal dominant disorderZunyan Dai, Zachary Whitt, Lindsey C Mighion, et al.
Neoplasia (New York, N.Y.)|September 27, 2003
RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancerJie Li, Zhongqiu Zhang, Zunyan Dai, et al.
Cancer Chemotherapy and Pharmacology|August 15, 2006
Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxiaXianhua Cao, Lanyan Fang, Seth Gibbs, et al.
Pharmaceutical Research|April 26, 2007
Chemogenomic analysis identifies geldanamycins as substrates and inhibitors of ABCB1Ying Huang, Paul E Blower, Ruqing Liu, et al.
Oncogene|February 28, 2003
LOH of chromosome 12p correlates with Kras2 mutation in non-small cell lung cancerJie Li, Zhongqiu Zhang, Zunyan Dai, et al.
Cancer Research|June 19, 2004
Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistanceYing Huang, Pascale Anderle, Kimberly J Bussey, et al.
Molecular and Cellular Biology|May 30, 2003
Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoterWei-Guo Zhu, Kanur Srinivasan, Zunyan Dai, et al.
The Journal of Biological Chemistry|January 15, 2004
5-aza-2'-deoxycytidine activates the p53/p21Waf1/Cip1 pathway to inhibit cell proliferationWei-Guo Zhu, Theresa Hileman, Yang Ke, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 7, 2005
Efflux of depsipeptide FK228 (FR901228, NSC-630176) is mediated by P-glycoprotein and multidrug resistance-associated protein 1Jim J Xiao, Amy B Foraker, Peter W Swaan, et al.
Pageof 4